CXCL10 and COVID-19: SARS-CoV-2 infection triggers extensive production of pro-inflammatory molecules such as CRP, TNF-α, IL-1β, IL-6, MIP-1α, IP-10 and IL-10 by activated inflammatory monocytes and neutrophils recruited into the lungs of COVID-19 patients (32–34).